Executive Team

Jeff co-founded Clinipace Worldwide in 2003 with the idea of building a clinical research company that would take a different approach to managing clinical trials. He wanted to build a company where technology served as the foundation of the research.  At Clinipace Worldwide, technology is in our DNA with Jeff and his team successfully delivering a technology-amplified approach to conducting research resulting in strong year-over-year growth.

Chris co-founded Clinipace Worldwide and currently services as president and general counsel. In this role, Chris leads corporate and business development, legal affairs, medical affairs, human resources, therapeutic leadership, regulatory & strategic development, and corporate quality assurance.

Mark joins Clinipace Worldwide through its acquisition of Paragon Biomedical and leads the company’s global clinical service delivery organization, including clinical operations (project management & monitoring), global central services (biostatistics, site management & data management), and pharmacovigilance & patient safety management.

Daryl leads the service engineering, product engineering and cloud computing infrastructure teams.

Daryl holds an MSE in Computer Science from Princeton University, a BS in Mathematical Sciences from the University of North Carolina at Chapel Hill, and is a member of Phi Beta Kappa.